Application
Dot blot analysis of Phospho-APG4D-S341 Antibody on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Product Name | Phospho-ATG4D-S341 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Modification | p-S341 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | DB |
| DB:1:500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | APG4D, AUTL4 |
|---|---|
| Alternative Names | ATG4D APG4D AUTL4 Cysteine protease ATG4D AUT-like 4 cysteine endopeptidase Autophagin-4 Autophagy-related cysteine endopeptidase 4 Autophagy-related protein 4 homolog D |
| Molecular Weight(MW) | 52922 Da |
| Function | Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes |
| Tissue Specificity | Mainly expressed in skeletal muscle and, to a lower extent, in testis |
| Cellular Localization | Cytoplasm (Probable). |
| Entrez Gene | 84971 |
|---|
Application
Dot blot analysis of Phospho-APG4D-S341 Antibody on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Application Notes | DB:1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is first purified by protein A affinity chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with peptides. The antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. |
